BioNTech SEVerified account

@BioNTech_Group

Our vision is to harness the power of the immune system to develop novel therapies based on groundbreaking R&D with cutting-edge technologies

Joined November 2018

Tweets

You blocked @BioNTech_Group

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @BioNTech_Group

  1. May 31

    The expanded the conditional marketing authorization for our vaccine to incl. individuals 12-15rys of age. Our pediatric studies evaluating the safety & efficacy of our vaccine in children from the ages of 6mths - 11yrs are ongoing.

    Undo
  2. Retweeted

    We are working closely with our industrial partners to supply vaccines to low & middle income countries. They just pledged to make available 1.3 billion doses to these countries in 2021. 1 billion from 200 million from 100m from

    Undo
  3. May 21

    We have published our first Sustainability Report. The publication is a milestone for us, showcasing not only the contribution we aspire to make to society through our innovative research, but also the wider responsibility we take on as a company.

    Undo
  4. Retweeted

    Our new 🇪🇺 contract 2021-2023 with is now signed. It guarantees up to 1.8 billion doses for our fight against COVID and its variants. Contracts with other companies may follow, to protect Europe and the world in the long term.

    Undo
  5. May 20

    We plan to supply the EU with up to 1.8b additional doses of our vaccine & entered a new agreement with the to supply 900m doses of our COVID-19 vaccine to the EU, with an option to request up to an additional 900m doses.

    Undo
  6. May 18

    Welcoming Jens Holstein to our team as of Jul. 1 as our new CFO. Dr. Sierk Poetting will hand over the CFO role to Jens to completely focus on his tasks as COO.

    Undo
  7. May 17

    . has approved a change to the existing storage conditions for our vaccine: The thawed, undiluted vaccine can be stored at fridge temperatures of 2-8°C for 1 month, instead of 5 days at fridge temperatures, as previously indicated.

    Undo
  8. May 11

    The has expanded the EUA for our based vaccine to include adolescents 12-15 yrs. This is an important milestone in our efforts to help address the global pandemic and to return to normalcy.

    Undo
  9. May 10

    Q1 updates: we delivered > 450m doses of our COVID-19 vaccine globally. We’ll further optimize our technologies and expand our pipeline as we meet our ambition to become a global, fully-integrated immunotherapy company.

    Undo
  10. May 9

    We’re excited to announce our plans to establish our first regional hub in region & 1st manufacturing facility in – expanding our ability to manufacture & deliver vaccines & potential therapies to people around the world

    Undo
  11. May 6

    オリンピック・パラリンピック競技大会の参加選手と代表団に、新型コロナウイルスのワクチンを無償提供することを誇りに思います。このような特別なイベントへの支援機会を提供してくれた に感謝します。

    Undo
  12. May 6

    We are proud to provide doses of our vaccine to help vaccinate athletes & delegations in the Olympic & Paralympic Games . We thank the for the opportunity to support this extraordinary event in these times.

    Undo
  13. May 3

    Curious about the future of ? Our Chief Medical Officer, Özlem Türeci, shared our vision for the potential of technology at the event. Thank you for providing such an important platform.

    Undo
  14. Apr 30

    We’ve just submitted a request for a variation of our Conditional Marketing Authorization to for our vaccine to be extended to adolescents 12-15 yrs.

    Undo
  15. Apr 27

    We’re excited to be in ’s first 100 Most Influential Companies list. This honors the hard work of our & colleagues, who went above & beyond to develop & manufacture our COVID-19 vaccine in light speed.

    Undo
  16. Retweeted

    Ich bin froh, heute den Standort in Purrs zu besuchen. Die Impfungen in der EU schreiten dank verlässlichen Partnern wie & zügig voran. So können wir bereits bis zum Juli 70 Prozent aller Erwachsenen ein Impfangebot machen.

    Show this thread
    Undo
  17. Apr 20

    We welcomed to our site in Marburg for a unique behind-the-scenes look at all steps involved in manufacturing our based vaccine. We are so proud of our whose hard work has contributed to a global solution. The video shows some of our heroes.

    Undo
  18. Apr 19

    “What we have seen in the COVID-19 field is just the beginning” said Ugur Sahin in regards to mRNA at this year’s Virtual Health Summit by . Watch the whole talk here:

    Undo
  19. Apr 12

    This week, the first vaccines manufactured in Marburg will be distributed to various European countries! What does one of the largest COVID-19 production facilities in Europe look like? Here is “where the magic happens”

    Undo
  20. Apr 1

    Our vaccine is 91.3% efficacious 7 days through up to 6 months after the 2nd dose. Results are based on 46,307 trial participants (>12k received the vaccine 6 months ago) demonstrating strong protection.

    Undo

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·